BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Price AM, Luftig MA. Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation. Adv Virus Res 2014;88:279-313. [PMID: 24373315 DOI: 10.1016/B978-0-12-800098-4.00006-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Price AM, Luftig MA. To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis. PLoS Pathog 2015;11:e1004656. [PMID: 25790223 DOI: 10.1371/journal.ppat.1004656] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 8.7] [Reference Citation Analysis]
2 Meier UC, Cipian RC, Karimi A, Ramasamy R, Middeldorp JM. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis. Front Immunol 2021;12:757302. [PMID: 34790199 DOI: 10.3389/fimmu.2021.757302] [Reference Citation Analysis]
3 Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol 2020;11:587380. [PMID: 33488588 DOI: 10.3389/fimmu.2020.587380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Zhang C, Zhang R, Chen Z, Chen J, Ruan J, Lu Z, Xiong H, Yang W. Differential DNA methylation profiles of human B lymphocytes and Epstein-Barr virus-immortalized B lymphocytes. Chin J Cancer Res 2018;30:104-11. [PMID: 29545724 DOI: 10.21147/j.issn.1000-9604.2018.01.11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhang Y, Fu Q, Zhang X. The presence of human papillomavirus and Epstein-Barr virus in male Chinese lichen sclerosus patients: a single center study. Asian J Androl 2016;18:650-3. [PMID: 26289401 DOI: 10.4103/1008-682X.160261] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gru AA, Haverkos BH, Freud AG, Hastings J, Nowacki NB, Barrionuevo C, Vigil CE, Rochford R, Natkunam Y, Baiocchi RA, Porcu P. The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment. Curr Hematol Malig Rep 2015;10:456-67. [PMID: 26449716 DOI: 10.1007/s11899-015-0292-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
7 van Zyl DG, Mautner J, Delecluse HJ. Progress in EBV Vaccines. Front Oncol 2019;9:104. [PMID: 30859093 DOI: 10.3389/fonc.2019.00104] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
8 Dolgova EV, Petrova DD, Proskurina AS, Ritter GS, Kisaretova PE, Potter EA, Efremov YR, Bayborodin SI, Karamysheva TV, Romanenko MV, Netesov SV, Taranov OS, Ostanin AA, Chernykh ER, Bogachev SS. Identification of the xenograft and its ascendant sphere-forming cell line as belonging to EBV-induced lymphoma, and characterization of the status of sphere-forming cells. Cancer Cell Int 2019;19:120. [PMID: 31080361 DOI: 10.1186/s12935-019-0842-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chen X, Kamranvar SA, Masucci MG. Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors. Oncogene 2016;35:3807-16. [PMID: 26592445 DOI: 10.1038/onc.2015.450] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
10 Murata T, Sugimoto A, Inagaki T, Yanagi Y, Watanabe T, Sato Y, Kimura H. Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation. Viruses 2021;13:2344. [PMID: 34960613 DOI: 10.3390/v13122344] [Reference Citation Analysis]
11 Singh S, Jha HC. Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer. J Oncol 2017;2017:3456264. [PMID: 28421114 DOI: 10.1155/2017/3456264] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
12 Price AM, Dai J, Bazot Q, Patel L, Nikitin PA, Djavadian R, Winter PS, Salinas CA, Barry AP, Wood KC, Johannsen EC, Letai A, Allday MJ, Luftig MA. Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection. Elife 2017;6:e22509. [PMID: 28425914 DOI: 10.7554/eLife.22509] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
13 Krump NA, You J. Molecular mechanisms of viral oncogenesis in humans. Nat Rev Microbiol. 2018;16:684-698. [PMID: 30143749 DOI: 10.1038/s41579-018-0064-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 16.3] [Reference Citation Analysis]
14 van Diemen FR, Kruse EM, Hooykaas MJ, Bruggeling CE, Schürch AC, van Ham PM, Imhof SM, Nijhuis M, Wiertz EJ, Lebbink RJ. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections. PLoS Pathog 2016;12:e1005701. [PMID: 27362483 DOI: 10.1371/journal.ppat.1005701] [Cited by in Crossref: 151] [Cited by in F6Publishing: 139] [Article Influence: 25.2] [Reference Citation Analysis]
15 Pancholi NJ, Price AM, Weitzman MD. Take your PIKK: tumour viruses and DNA damage response pathways. Philos Trans R Soc Lond B Biol Sci 2017;372:20160269. [PMID: 28893936 DOI: 10.1098/rstb.2016.0269] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
16 El-Sharkawy A, Al Zaidan L, Malki A. Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis. Front Oncol 2018;8:265. [PMID: 30116721 DOI: 10.3389/fonc.2018.00265] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
17 Thorley-Lawson DA. EBV Persistence--Introducing the Virus. Curr Top Microbiol Immunol 2015;390:151-209. [PMID: 26424647 DOI: 10.1007/978-3-319-22822-8_8] [Cited by in Crossref: 56] [Cited by in F6Publishing: 97] [Article Influence: 9.3] [Reference Citation Analysis]
18 Messinger JE, Dai J, Stanland LJ, Price AM, Luftig MA. Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III. mBio 2019;10:e01006-19. [PMID: 31266868 DOI: 10.1128/mBio.01006-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
19 Chen S, Yu X, Guo D. CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy. Viruses 2018;10:E40. [PMID: 29337866 DOI: 10.3390/v10010040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
20 Coleman CB, Wohlford EM, Smith NA, King CA, Ritchie JA, Baresel PC, Kimura H, Rochford R. Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. J Virol 2015;89:2301-12. [PMID: 25505080 DOI: 10.1128/JVI.03001-14] [Cited by in Crossref: 56] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
21 Mrozek-Gorska P, Buschle A, Pich D, Schwarzmayr T, Fechtner R, Scialdone A, Hammerschmidt W. Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection. Proc Natl Acad Sci U S A 2019;116:16046-55. [PMID: 31341086 DOI: 10.1073/pnas.1901314116] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
22 Ben-Dayan MM, MacCarthy T, Schlecht NF, Belbin TJ, Childs G, Smith RV, Prystowsky MB, Bergman A. Cancer as the Disintegration of Robustness: Population-Level Variance in Gene Expression Identifies Key Differences Between Tobacco- and HPV-Associated Oropharyngeal Carcinogenesis. Arch Pathol Lab Med 2015;139:1362-72. [PMID: 26132601 DOI: 10.5858/arpa.2014-0624-OA] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
23 Frappier L. Epstein-Barr virus: Current questions and challenges. Tumour Virus Res 2021;12:200218. [PMID: 34052467 DOI: 10.1016/j.tvr.2021.200218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Leung A, Trac C, Kato H, Costello KR, Chen Z, Natarajan R, Schones DE. LTRs activated by Epstein-Barr virus-induced transformation of B cells alter the transcriptome. Genome Res 2018;28:1791-8. [PMID: 30381291 DOI: 10.1101/gr.233585.117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Moormann AM, Bailey JA. Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis. Curr Opin Virol 2016;20:78-84. [PMID: 27689909 DOI: 10.1016/j.coviro.2016.09.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
26 Houen G, Trier NH, Frederiksen JL. Epstein-Barr Virus and Multiple Sclerosis. Front Immunol 2020;11:587078. [PMID: 33391262 DOI: 10.3389/fimmu.2020.587078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Zheng X, Wang J, Zhang X, Fu Y, Peng Q, Lu J, Wei L, Li Z, Liu C, Wu Y, Yan Q, Ma J. RNA m6 A methylation regulates virus-host interaction and EBNA2 expression during Epstein-Barr virus infection. Immun Inflamm Dis 2021;9:351-62. [PMID: 33434416 DOI: 10.1002/iid3.396] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
28 Hassani A, Corboy JR, Al-Salam S, Khan G. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS One 2018;13:e0192109. [PMID: 29394264 DOI: 10.1371/journal.pone.0192109] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 11.3] [Reference Citation Analysis]
29 Wille CK, Li Y, Rui L, Johannsen EC, Kenney SC. Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency. J Virol 2017;91:e01987-16. [PMID: 28003489 DOI: 10.1128/JVI.01987-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
30 Stanland LJ, Luftig MA. Molecular features and translational outlook for Epstein-Barr virus-associated gastric cancer. Future Virol 2018;13:803-18. [PMID: 34367314 DOI: 10.2217/fvl-2018-0071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Frost TC, Gewurz BE. Epigenetic crossroads of the Epstein-Barr virus B-cell relationship. Curr Opin Virol 2018;32:15-23. [PMID: 30227386 DOI: 10.1016/j.coviro.2018.08.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
32 Zelazowska MA, Dong Q, Plummer JB, Zhong Y, Liu B, Krug LT, McBride KM. Gammaherpesvirus-infected germinal center cells express a distinct immunoglobulin repertoire. Life Sci Alliance 2020;3:e201900526. [PMID: 32029571 DOI: 10.26508/lsa.201900526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L, Han MH. Molecular signature of Epstein-Barr virus infection in MS brain lesions. Neurol Neuroimmunol Neuroinflamm 2018;5:e466. [PMID: 29892607 DOI: 10.1212/NXI.0000000000000466] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
34 Eisenreich W, Rudel T, Heesemann J, Goebel W. How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication. Front Cell Infect Microbiol 2019;9:42. [PMID: 30886834 DOI: 10.3389/fcimb.2019.00042] [Cited by in Crossref: 76] [Cited by in F6Publishing: 59] [Article Influence: 25.3] [Reference Citation Analysis]